Stately Bio develops cell therapies using a machine learning-powered live-cell imaging platform to enhance process development and quality control for biopharma companies.

Aspect Biosystems develops bioprinted tissue therapeutics to treat serious metabolic and endocrine diseases using AI-powered bioprinting technology.

Enveda is a biotechnology company that uses AI and metabolomics to accelerate drug discovery.